News for Healthier Living

Roswell Park-Led Clinical Trial Paves Way for FDA Approval of Targeted Drug for Aggressive Leukemia

The U.S. Food and Drug Administration has approved a new drug to treat an aggressive form of leukemia, based on the results of a clinical trial co-led by Eunice Wang, MD, Chief of Leukemia at Roswell Park Comprehensive Cancer Center.

December 2, 2025


December 6 2025

December 5 2025

December 4 2025

December 3 2025

December 2 2025

December 1 2025

November 30 2025

November 29 2025

November 28 2025

November 27 2025

November 26 2025

November 25 2025

November 24 2025

November 23 2025